Connecticut Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Sell |
757
-31
| -4% | -$16.3K | 0.02% | 229 |
|
|
2025
Q1 | $500K | Buy |
788
+26
| +3% | +$16.5K | 0.03% | 211 |
|
|
2024
Q4 | $543K | Buy |
762
+4
| +0.5% | +$2.85K | 0.03% | 178 |
|
|
2024
Q3 | $797K | Sell |
758
-86
| -10% | -$90.4K | 0.04% | 178 |
|
|
2024
Q2 | $887K | Sell |
844
-165
| -16% | -$173K | 0.05% | 163 |
|
|
2024
Q1 | $971K | Buy |
1,009
+13
| +1% | +$12.5K | 0.05% | 151 |
|
|
2023
Q4 | $875K | Sell |
996
-187
| -16% | -$164K | 0.05% | 157 |
|
|
2023
Q3 | $974K | Hold |
1,183
| – | – | 0.07% | 118 |
|
|
2023
Q2 | $850K | Hold |
1,183
| – | – | 0.06% | 109 |
|
|
2023
Q1 | $972K | Hold |
1,183
| – | – | 0.07% | 97 |
|
|
2022
Q4 | $854K | Sell |
1,183
-1
| -0.1% | -$721 | 0.07% | 90 |
|
|
2022
Q3 | $816K | Sell |
1,184
-1
| -0.1% | -$689 | 0.08% | 87 |
|
|
2022
Q2 | $700K | Sell |
1,185
-3
| -0.3% | -$1.77K | 0.06% | 102 |
|
|
2022
Q1 | $830K | Hold |
1,188
| – | – | 0.06% | 94 |
|
|
2021
Q4 | $750K | Sell |
1,188
-2
| -0.2% | -$1.26K | 0.06% | 98 |
|
|
2021
Q3 | $720K | Buy |
1,190
+174
| +17% | +$105K | 0.06% | 96 |
|
|
2021
Q2 | $567K | Hold |
1,016
| – | – | 0.05% | 113 |
|
|
2021
Q1 | $481K | Hold |
1,016
| – | – | 0.04% | 101 |
|
|
2020
Q4 | $491K | Sell |
1,016
-3
| -0.3% | -$1.45K | 0.05% | 109 |
|
|
2020
Q3 | $570K | Buy |
1,019
+19
| +2% | +$10.6K | 0.06% | 111 |
|
|
2020
Q2 | $624K | Hold |
1,000
| – | – | 0.08% | 78 |
|
|
2020
Q1 | $488K | Hold |
1,000
| – | – | 0.07% | 93 |
|
|
2019
Q4 | $375K | Hold |
1,000
| – | – | 0.04% | 122 |
|
|
2019
Q3 | $277K | Hold |
1,000
| – | – | 0.03% | 133 |
|
|
2019
Q2 | $313K | Buy |
+1,000
| New | +$313K | 0.04% | 124 |
|